Eastwood Historical Income Statement

Stocks . Canada . 
Stock . Eastwood Bio Medical Canada
EBM Stock  CAD 0.75  0.05  6.25%   
Historical analysis of Eastwood Bio income statement accounts such as Selling And Marketing Expenses of 2.8 K or Total Revenue of 907.6 K can show how well Eastwood Bio Medical Canada performed in making a profits. Evaluating Eastwood Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Eastwood Bio's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Eastwood Bio Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eastwood Bio Medical is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Eastwood Income Statement Analysis

Eastwood Bio Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Eastwood Bio shareholders. The income statement also shows Eastwood investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

Eastwood Bio Income Statement Chart

At this time, Eastwood Bio's Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 858.4 K in 2024, whereas Total Revenue is likely to drop slightly above 907.6 K in 2024.
Selling General Administrative  Selling And Marketing Expenses  Total Revenue  Gross Profit  
Add Fundamental

Total Revenue

Total revenue comprises all receipts Eastwood Bio Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Eastwood Bio Medical Canada minus its cost of goods sold. It is profit before Eastwood Bio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Eastwood Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Eastwood Bio Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eastwood Bio Medical Canada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Eastwood Bio's Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 858.4 K in 2024, whereas Total Revenue is likely to drop slightly above 907.6 K in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit902.7K440.5K506.6K439.0K
Total Revenue1.3M867.9K998.1K907.6K

Eastwood Bio income statement Correlations

Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Depreciation And Amortization
Net Interest Income
Reconciled Depreciation
Interest Expense
0.060.380.120.150.23-0.18-0.470.190.270.050.29-0.47-0.9-0.47-0.830.270.50.17
Selling General Administrative
0.06-0.160.540.270.83-0.64-0.6-0.63-0.520.570.88-0.6-0.09-0.610.050.590.010.59
Selling And Marketing Expenses
0.38-0.16-0.42-0.46-0.22-0.26-0.40.06-0.06-0.22-0.06-0.4-0.52-0.39-0.73-0.590.8-0.6
Total Revenue
0.120.54-0.420.760.80.060.00.030.170.810.490.0-0.110.00.080.54-0.130.51
Gross Profit
0.150.27-0.460.760.350.480.360.450.590.240.260.36-0.130.360.080.47-0.150.45
Other Operating Expenses
0.230.83-0.220.80.35-0.55-0.56-0.52-0.380.880.83-0.56-0.19-0.56-0.020.65-0.050.63
Operating Income
-0.18-0.64-0.260.060.48-0.550.940.90.88-0.35-0.670.940.170.940.16-0.27-0.15-0.3
Net Income From Continuing Ops
-0.47-0.6-0.40.00.36-0.560.940.710.67-0.32-0.651.00.51.00.46-0.3-0.38-0.28
Ebit
0.19-0.630.060.030.45-0.520.90.710.98-0.36-0.610.71-0.250.71-0.29-0.340.25-0.39
Ebitda
0.27-0.52-0.060.170.59-0.380.880.670.98-0.28-0.490.67-0.30.67-0.27-0.130.17-0.19
Cost Of Revenue
0.050.57-0.220.810.240.88-0.35-0.32-0.36-0.280.5-0.32-0.04-0.320.050.39-0.060.36
Total Operating Expenses
0.290.88-0.060.490.260.83-0.67-0.65-0.61-0.490.5-0.65-0.17-0.66-0.060.63-0.040.66
Income Before Tax
-0.47-0.6-0.40.00.36-0.560.941.00.710.67-0.32-0.650.51.00.46-0.3-0.38-0.28
Total Other Income Expense Net
-0.9-0.09-0.52-0.11-0.13-0.190.170.5-0.25-0.3-0.04-0.170.50.50.93-0.11-0.75-0.01
Net Income
-0.47-0.61-0.390.00.36-0.560.941.00.710.67-0.32-0.661.00.50.45-0.3-0.38-0.29
Income Tax Expense
-0.830.05-0.730.080.08-0.020.160.46-0.29-0.270.05-0.060.460.930.450.2-0.890.27
Depreciation And Amortization
0.270.59-0.590.540.470.65-0.27-0.3-0.34-0.130.390.63-0.3-0.11-0.30.2-0.460.97
Net Interest Income
0.50.010.8-0.13-0.15-0.05-0.15-0.380.250.17-0.06-0.04-0.38-0.75-0.38-0.89-0.46-0.5
Reconciled Depreciation
0.170.59-0.60.510.450.63-0.3-0.28-0.39-0.190.360.66-0.28-0.01-0.290.270.97-0.5
Click cells to compare fundamentals

Eastwood Bio Account Relationship Matchups

High Positive Relationship

Income Before Tax
+ 1.0
Net Income From Continuing Ops
Net Income
+ 1.0
Net Income From Continuing Ops
Net Income
+ 1.0
Income Before Tax
Ebitda
+ 0.98
Ebit
Reconciled Depreciation
+ 0.97
Depreciation And Amortization
Net Income From Continuing Ops
+ 0.94
Operating Income

High Negative Relationship

Total Other Income Expense Net
- 0.9
Interest Expense
Net Interest Income
- 0.89
Income Tax Expense
Income Tax Expense
- 0.83
Interest Expense
Net Interest Income
- 0.75
Total Other Income Expense Net
Income Tax Expense
- 0.73
Selling And Marketing Expenses
Total Operating Expenses
- 0.67
Operating Income

Eastwood Bio income statement Accounts

201920202021202220232024 (projected)
Interest Expense2.4K2.8K10.7K28.2K32.4K34.0K
Selling General Administrative1.1M951.8K922.5K666.7K766.7K858.4K
Selling And Marketing Expenses33.9K16.5K2.7K3.3K3.0K2.8K
Total Revenue718.3K981.1K1.3M867.9K998.1K907.6K
Gross Profit213.3K458.4K902.7K440.5K506.6K439.0K
Other Operating Expenses1.6M1.6M1.4M1.4M1.6M1.4M
Operating Income(838.7K)(590.9K)(128.8K)(506.0K)(455.4K)(478.2K)
Net Income From Continuing Ops(852.4K)(603.6K)(149.9K)(546.6K)(491.9K)(516.5K)
Ebit(838.7K)(590.9K)(128.8K)(506.0K)(455.4K)(478.2K)
Ebitda(732.9K)(485.6K)(21.9K)(398.2K)(358.4K)(376.3K)
Cost Of Revenue505.0K522.7K397.0K427.4K491.5K468.5K
Total Operating Expenses1.1M1.1M1.0M946.6K1.1M990.7K
Income Before Tax(852.4K)(603.6K)(149.9K)(546.6K)(491.9K)(516.5K)
Total Other Income Expense Net(13.8K)(12.7K)(21.1K)(40.6K)(36.5K)(38.3K)
Net Income Applicable To Common Shares(577.3K)(852.4K)(603.6K)(149.9K)(134.9K)(141.6K)
Net Income(860.0K)(611.3K)(160.6K)(546.6K)(491.9K)(516.5K)
Income Tax Expense7.6K7.7K10.7K(1.0)(1.15)(1.21)
Depreciation And Amortization105.7K105.3K106.9K107.9K124.0K130.2K
Net Interest Income(1.0K)(2.8K)(10.7K)(28.2K)(25.3K)(24.1K)
Reconciled Depreciation105.7K105.3K106.9K107.9K124.0K91.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY